PD-013RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC). (2nd July 2019) - Sunakawa, Y; Nakamura, M; Ishizaki, M; Kataoka, M; Satake, H; Kitazono, M; Yanagisawa, H; Kawamoto, Y; Kuramochi, H; Ohori, H; Nakamura, M; Takahashi, K; et al.